telephone:+86 15850741984
Database CN
  • Home
  • About
    Company Profile

    Team Introduction

    Join Us

  • Product
    GPCR

    Kinase

    Drug Resistant

    Tracer Cell

    Immunotherapy

    Diagnostic Standards

    Mutation Reference Fusion Reference CNV Reference Translocation Standard MRD NIPT NGS Panel Standards DdPCR probe primer Virus standard Medication guidance Other Thalassemia Genetic deafness SMA-SMN1/2 Pathogen Standard Methylation standards

    Reporter Gene

    COVID-19 Target

    hIO-Mouse

    Luciferase Assay Kit

    DdPCR Detection Kit

    Other

  • Services
    Cell Engineering Services

    Stable Cell Line Construction Cellular RNAi Technology

    Drug Screening Services

    GPCR Targeted Drug Evaluation Kinase Targeted Drug Evaluation Immunotherapy Targeted Drug Evaluation

    Molecular Biology Services

    CRISPR-Cas9 sgRNA library synthesis DDPCR detection STR Identification

    Virus Packaging Service

    fake virus packaging Lentiviral Packaging Adenovirus Packaging

    Antibody Expression Service

    Antibody Expression Service

    Gene Editing Services

    Gene Editing Services

  • News
    Company News

    Promotions

    Industry News

  • Resources
    Technical Column

    Course Video

    Download

  • Contact
    Contact Us

    Online Message

  • Right Side Column
    Promotions

    Related Products

    Related Services

    Gene Synthesis

  • Company News
  • Promotions
  • Industry News
  • A new target for enhancing tumor immunotherapy: ADORA2B (adenosine A2B receptor)

    Introduction to Adenosine ReceptorsAdenosine plays an important role in various physiological...

    2022-06-30
  • Fourth-generation ALK kinase inhibitor screening model

    backgroundChromosomal rearrangements of the anaplastic lymphoma kinase (ALK) gene produce oncogenic ...

    2022-06-24
  • Have you participated in MRD testing for ctDNA?

    MRD refers to residual tumor cells or markers in the body after treatment. There are usually three...

    2022-06-16
  • Iterative breakthrough innovation of old targets: Her2 target cell model

    The ASCO meeting in 2022 is about to be held. Judging from some of the published abstracts, the Her2...

    2022-05-31
  • "Diamond mutation" ALK gene diagnosis

    Recently, Pfizer announced that the world’s first third-generation ALK inhibitor, Lorbrena® ...

    2022-05-26
  • CCR8 | Potential blockbuster tumor immunotherapy target

    Introduction to CCR8CCR8 is a member of the chemokine receptor family and is a G protein-coupled...

    2022-05-12
  • The Tumor Suppressor Gene PTEN You Must Know

    Introduction to PTENPTEN gene (chromosome 10 homology loss phosphatase tensin gene), located on...

    2022-04-22
  • GM-CSF, a new therapeutic target for cytokine storm and autoimmune inflammation

    Cytokine stormsyndromes (CSS) are caused by a variety of cytokines in body fluids such as IL-1, IL-6...

    2022-04-15
  • Migraines to the rescue! Research progress of CGRP and its receptor antagonists

    BackgroundMigraine is a complex neurovascular disease that affects approximately 12% of the...

    2022-04-06
  • 【Target Model】Drug Development of AKT Gene

    The serine/threonine kinase AKT, also known as protein kinase B (PKB), is a key component of the...

    2022-03-29
previous page
3 4 5 6 7 8 ...
next page
Product
GPCR
Kinase
Drug Resistant
Tracer Cell
Immunotherapy
Diagnostic Standards
Reporter Gene
COVID-19 Target
hIO-Mouse
Luciferase Assay Kit
DdPCR Detection Kit
Other
Services
Cell Engineering Services
Drug Screening Services
Molecular Biology Services
Virus Packaging Service
Antibody Expression Service
Gene Editing Services
Contact

E-mail:sales@reqbio.com

Add:3rd Floor, No. 6, Lane 222, 

Guangdan Road, Pudong New Area,

 Shanghai,China


Links

WeChat public account

About Contact Company News

Copyright ©2016 www.reqbio.com All Rights Reserved. REQBIO (SHANGHAI) BIOSCIENCES CO., LTD All Rights Reserved Shanghai ICP No. 19008200-1